Comparison of effectiveness and safety between conbercept and ranibizumab for treatment of neovascular age-related macular degeneration. A retrospective case-controlled non-inferiority multiple center study

Comparison of effectiveness and safety between conbercept and ranibizumab for treatment of neovascular age-related macular degeneration. A retrospective case-controlled non-inferiority multiple center studyEye, Published online: 22 September 2017; doi:10.1038/eye.2017.187

https://www.nature.com/articles/eye2017187

Source: Eye - September 22, 2017 Category: Opthalmology Authors: J Cui D Sun H Lu R Dai L Xing H Dong L Wang D Wei B Jiang Y Jiao M M Jablonski S Charles W Gu H Chen Source Type: research

More News: Age-Related Macular Degeneration (AMD) | Lucentis | Ranibizumab Injection | Study